Charting Only., page-217

Biotech companies - researching immunotherapies , particularly in combination therapy , it’s just a very slow Path.
Changes in tack required often along the pathway .

Leslie Chong is a highly credentialed, intelligent & genuine leader , I think .

She is usually willing to spend the time explaining scientific basis of the trials and past findings to shareholders , or people with questions , whenever she is available .
Have enormous respect for her .
Wow - that she came out to Australia , to join Imugene .
She will never give up , is my impression of her from over several years now .

In the news -for information all .
Is tough going for immunotherapy based, small -cap biotech researchers.
(though the work they’re doing is considered to be vitally important . ) Be fantastic, excellent - if Imugene immunotherapy for no- hope and more dire cancer prognosis sufferers gains success :

https://investingnews.com/daily/lif...n-state-future-immunotherapies/?mqsc=E4024631